Notice2021-26593
National Cancer Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 8, 2021
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 233 (Wednesday, December 8, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 233 (Wednesday, December 8, 2021)]
[Notices]
[Pages 69660-69661]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-26593]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and contract proposals and
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications and
contract proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Outstanding Investigator Award.
Date: January 20-21, 2022.
Time: 9:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W530, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Shamala K. Srinivas, Ph.D., Associate Director,
Office of Referral, Review, and Program Coordination, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W530, Rockville, Maryland 20850, 240-276-6442,
<a href="/cdn-cgi/l/email-protection#c0b3b3f5f3f7b480aea9a8eea7afb6"><span class="__cf_email__" data-cfemail="4f3c3c7a7c783b0f21262761282039">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Division of Cancer Epidemiology and Genetics (DCEG) Field and
Biospecimen Support Services.
Date: January 20, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850, 240-276-5460,
<a href="/cdn-cgi/l/email-protection#1e74787f70795e737f77723070777630797168"><span class="__cf_email__" data-cfemail="18727e79767f587579717436767170367f776e">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Trials Support Unit TEP 1A.
Date: January 27, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W608, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W608, Rockville, Maryland 20850, 240-276-5856,
<a href="/cdn-cgi/l/email-protection#1a747b7e7f7f773471727b745a747372347d756c"><span class="__cf_email__" data-cfemail="e789868382828ac98c8f8689a7898e8fc9808891">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Trials Support Unit TEP 1B.
Date: January 28, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W608, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W608, Rockville, Maryland 20850, 240-276-5856,
<a href="/cdn-cgi/l/email-protection#d8b6b9bcbdbdb5f6b3b0b9b698b6b1b0f6bfb7ae"><span class="__cf_email__" data-cfemail="315f505554545c1f5a59505f715f58591f565e47">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-1A: SBIR Contract Review.
Date: February 1, 2022.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W412, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Ivan Ding, M.D., Health Scientist Administrator,
Division of Extramural Activities, Program and Review Extramural
Staff Training Office, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W412, Rockville, Maryland 20850, 240-276-6444,
<a href="/cdn-cgi/l/email-protection#e88c81868f81a885898184c6868180c68f879e"><span class="__cf_email__" data-cfemail="a8ccc1c6cfc1e8c5c9c1c486c6c1c086cfc7de">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-1B: SBIR Contract Review.
Date: February 2, 2022.
Time: 10:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W412, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Ivan Ding, M.D., Health Scientist Administrator,
Division of Extramural Activities, Program and Review Extramural
Staff Training Office, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W412, Rockville, Maryland 20850, 240-276-6444,
<a href="/cdn-cgi/l/email-protection#5034393e3739103d31393c7e3e39387e373f26"><span class="__cf_email__" data-cfemail="b1d5d8dfd6d8f1dcd0d8dd9fdfd8d99fd6dec7">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-3: NCI Clinical and Translational Cancer Research.
Date: February 3-4, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W236, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Shuli Xia, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W236, Rockville, Maryland 20850, 240-276-5256,
<a href="/cdn-cgi/l/email-protection#493a213c25206731202809272021672e263f"><span class="__cf_email__" data-cfemail="ee9d869b8287c096878fae808786c0898198">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-2: NCI Clinical and Translational Cancer Research.
Date: February 3-4, 2022.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W264, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Ombretta Salvucci, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W264, Rockville, Maryland 20850, 240-276-7286,
<a href="/cdn-cgi/l/email-protection#0e7d6f62787b6d6d614e636f67622060676620696178"><span class="__cf_email__" data-cfemail="65160409131006060a2508040c094b0b0c0d4b020a13">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Early Detection Research Network (U01, U24, U2C) Grant
Review.
Date: February 7-8, 2022.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W552, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Jeanette Irene Marketon, Ph.D., Scientific
Review Officer, Program Coordination and Referral Branch, Division
of Extramural Activities, 9609 Medical Center Drive, Room 7W552,
National Cancer Institute, NIH, Rockville, Maryland 20850, 240-276-
6780, <a href="/cdn-cgi/l/email-protection#aac0cfcbc4cfdedecf84c7cbd8c1cfdec5c4eac4c3c284cdc5dc"><span class="__cf_email__" data-cfemail="8ee4ebefe0ebfafaeba0e3effce5ebfae1e0cee0e7e6a0e9e1f8">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-3A: Cancer Treatment Technologies for Low-Resource
Settings.
Date: February 15-16, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850, 240-276-5460,
<a href="/cdn-cgi/l/email-protection#4e24282f20290e232f27226020272660292138"><span class="__cf_email__" data-cfemail="ee84888f8089ae838f8782c0808786c0898198">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Predoc
[[Page 69661]]
to Postdoc Fellow Transition Award (F99/K00).
Date: February 16-17, 2022.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W554, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Scott A. Chen, Ph.D., Chief, Scientific Review
Officer, Program Coordination and Referral Branch, Division of
Extramural Activities, 9609 Medical Center Drive, Room 7W554,
National Cancer Institute, NIH, Rockville, Maryland 20850, 240-276-
6038, <a href="/cdn-cgi/l/email-protection#e4878c818a9787a489858d88ca8a8d8cca838b92"><span class="__cf_email__" data-cfemail="82e1eae7ecf1e1c2efe3ebeeacecebeaace5edf4">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Technologies for Cancer Research.
Date: February 17-18, 2022.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W608, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W608, Rockville, Maryland 20850, 240-276-5856,
<a href="/cdn-cgi/l/email-protection#553b34313030387b3e3d343b153b3c3d7b323a23"><span class="__cf_email__" data-cfemail="701e111415151d5e1b18111e301e19185e171f06">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-3B: Cancer Prevention and Diagnosis Technologies for Low-
Resource Settings.
Date: February 23, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850, 240-276-5460,
<a href="/cdn-cgi/l/email-protection#ee84888f8089ae838f8782c0808786c0898198"><span class="__cf_email__" data-cfemail="f19b97909f96b19c90989ddf9f9899df969e87">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Prevention-Interception Targeted Agent Discovery
Program (CAP-IT) Centers.
Date: March 2-3, 2022.
Time: 10:00 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W238, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W238, Rockville, Maryland 20850, 240-276-7755,
<a href="/cdn-cgi/l/email-protection#adcfd4c8c2c3ca80cec5c8c183c1c8c8edc3c4c583cac2db"><span class="__cf_email__" data-cfemail="d6b4afb3b9b8b1fbb5beb3baf8bab3b396b8bfbef8b1b9a0">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-9: NCI Clinical and Translational Cancer Research.
Date: March 3, 2022.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W552, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Shannon M. Doyle, Ph.D., Scientific Review
Officer, Program Coordination and Referral Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9606 Medical
Center Drive, Room 7W552, Rockville, Maryland 20850, 202-731-8449,
<a href="/cdn-cgi/l/email-protection#6602091f0a0315260b070f0a48080f0e48010910"><span class="__cf_email__" data-cfemail="2e4a4157424b5d6e434f47420040474600494158">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-6: NCI Clinical and Translational Cancer Research.
Date: March 9, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850, 240-276-5460,
<a href="/cdn-cgi/l/email-protection#640e02050a032409050d084a0a0d0c4a030b12"><span class="__cf_email__" data-cfemail="deb4b8bfb0b99eb3bfb7b2f0b0b7b6f0b9b1a8">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Small-Cell Lung Cancer Consortium.
Date: March 10, 2022.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W238, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W238, Rockville, Maryland 20850, 240-276-7755,
<a href="/cdn-cgi/l/email-protection#adcfd4c8c2c3ca80cec5c8c183c1c8c8edc3c4c583cac2db"><span class="__cf_email__" data-cfemail="107269757f7e773d7378757c3e7c7575507e79783e777f66">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: December 3, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-26593 Filed 12-7-21; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 8, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.